ReviewInternational journal of molecular sciences2021

Personalized Medicine for TP53 Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia.

Thomas Cluzeau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.